• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Breast MRI CAD zeroes in on malignant lesions

Article

Results from two recent studies suggest computer-aided detection for breast MRI may be closing in on true cancer detection.

Results from two recent studies suggest computer-aided detection for breast MRI may be closing in on true cancer detection.

Researchers from Penn Diagnostics, a breast MRI CAD company, and George Washington University tested the ONCAD system for contrast-enhanced MRI. They reviewed images of 102 biopsy-proven breast cancers and 131 cancer-free breasts from six major U.S. research institutions. The investigators found ONCAD could identify up to 96% of true malignancies.

In another study, researchers from New York University and Siemens Medical Solutions presented results of a computer classification system designed to improve breast MRI BI-RADS classification. Forty patients were included in this study. The investigators found the automated classification tool yielded more accurate BI-RADS classifications than three radiologists blinded to results. Both studies were released at the 2008 ARRS meeting.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.